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Abstract
Emerging evidence has implicated the role of tumor initiating cells (TICs) in the process of cancer metastasis. The
mechanism underlying the conversion of TICs from stationary to invasive remains to be characterized. In this report, we
employed less invasive breast cancer TICs, SK-3rd, that displays CD44
high/CD24
low with high mammosphere-forming and
tumorigenic capacities, to investigate the mechanism by which stationary TICs are converted to invasive TICs. Invasive
ability of SK-3rd TICs was markedly enhanced when the cells were cultured under hypoxic conditions. Given the role of
membrane type 1-matrix metalloproteinase (MT1-MMP) in cancer invasion/metastasis, we explored a possible involvement
of MT1-MMP in hypoxia-induced TIC invasion. Silencing of MT1-MMP by a shRNA approach resulted in diminution of
hypoxia-induced cell invasion in vitro and metastasis in vivo. Under hypoxic conditions, MT1-MMP redistributed from
cytoplasmic storage pools to the cell surface of TICs, which coincides with the increased cell invasion. In addition, CD44, a
cancer stem-like cell marker, inversely correlated with increased cell surface MT1-MMP. Interestingly, cell surface MT1-MMP
gradually disappeared when the hypoxia-treated cells were switched to normoxia, suggesting the plasticity of TICs in
response to oxygen content. Furthermore, we dissected the pathways leading to upregulated MT1-MMP in cytoplasmic
storage pools under normoxic conditions, by demonstrating a cascade involving Twist1-miR10b-HoxD10 leading to
enhanced MT1-MMP expression in SK-3rd TICs. These observations suggest that MT1-MMP is a key molecule capable of
executing conversion of stationary TICs to invasive TICs under hypoxic conditions and thereby controlling metastasis.
Citation: Li J, Zucker S, Pulkoski-Gross A, Kuscu C, Karaayvaz M, et al. (2012) Conversion of Stationary to Invasive Tumor Initiating Cells (TICs): Role of Hypoxia in
Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) Trafficking. PLoS ONE 7(6): e38403. doi:10.1371/journal.pone.0038403
Editor: Zhongjun Zhou, The University of Hong Kong, Hong Kong
Received January 13, 2012; Accepted May 4, 2012; Published June 5, 2012
Copyright:  2012 Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported in part by NIH/NCI grants (R01CA113553 and R01CA166936) and the Carol Baldwin Breast Cancer Foundation (to J.C.); and a
Merit Review grant from the Department of Veterans Affairs (to S.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript. No additional external funding received for this study.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: jian.cao@sunysb.edu (JC); s_zucker@yahoo.com (SZ)
Introduction
Metastasis accounts for ,90% of all cancer deaths. Despite
considerable progress in our understanding of cancer biology,
leading to discovery of novel biological treatments, limitations in
our understanding of invasion/metastasis has stifled development
of anti-metastatic therapy.
Emerging studies have implicated cancer stem cells (CSCs)/
tumor initiating cells (TICs) in the process of invasion and
metastasis [1–3]. Based on therapeutic resistance of these cells to
chemotherapy, CSCs/TICs have also been implicated in tumor
recurrence. In view of the controversy surrounding the issue of
‘‘stemness’’, hereafter we will designate this cell population as
TICs. TICs are defined as a small subpopulation of tumor cells
that display both tumor-initiating ability and the capacity to
reconstitute the cellular heterogeneity of the original tumor. After
initial identification in acute myelogenous leukemia [4], TICs have
subsequently been isolated from many human solid tumors,
including breast cancer [5]. Although there is ongoing debate [6],
this subpopulation of cancer cells is acknowledged to give rise to
tumors following transplantation and to have self-renewal and
differentiation attributes. TICs share many of the properties of
normal stem cells including dormancy (quiescence) and resistance
to chemotherapy. Although the concept of tumor formation by
TICs is appreciated, a fundamental gap remains in our
understanding of how stationary TICs become invasive and
metastatic.
Experimental and clinical evidence has demonstrated that TIC
populations exhibit both migratory and invasive abilities [1] and
can be readily detected in various metastatic lesions in patients
with solid tumors [3,7]. It has been proposed that under certain
circumstances, TICs undergo epithelial-to-mesenchymal transition
(EMT), a developmental process in which epithelial cells acquire a
migratory mesenchymal phenotype. Brabletz et al. proposed that
TICs acquire two phenotypes: one that is associated with cell
growth and another that is migratory and characterized by
transient expression of EMT-associated genes [8]. This transition
can be reversed by a mesenchymal-to-epithelial (MET) transition,
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ary tumor formation at metastatic sites [8].
Previously, reports have demonstrated that the low oxygen
environment (hypoxia) that accompanies solid tumors induces
invasiveness of cancer cells with stem-like properties [9]. Further-
more, hypoxia exerts a physiological selection pressure that leads
to enhanced tumor invasion and metastasis [10].
Considerable evidence indicates that cancer cells and TICs
require proteases for their invasive behavior [11]. A key cell
surface anchored protease, membrane type 1-matrix metallopro-
teinase (MT1-MMP), plays a critical role in digesting basement
membrane and extracellular matrices (ECM) and in cancer cell
migration [12], hence promoting cancer invasion and metastasis.
We have previously demonstrated a role for MT1-MMP in EMT
[13]. In the current study, we employed a human breast cancer
TIC line, SK-3rd, to study the function of MT1-MMP in the
conversion of TICs from stationary to invasive cells. This TIC line
was isolated by sequential in vivo passage of SK-BR3 human breast
cancer cells in immuno-deficient mice undergoing treatment with
chemotherapy [14]. We demonstrated that hypoxia induces MT1-
MMP trafficking from cytoplasmic storage pools to the plasma
membrane, promoting TICs invasion.
Results
Hypoxia Promotes TIC Invasion
The mechanism by which stationary TICs convert to their
metastatic counterpart and then return to stationary status at the
metastatic site remains to be characterized. To study this
phenomenon, we employed a previously established and well
characterized TIC line, SK-3rd [14]. These cells display a cancer
stem-like cell phenotype including self-renewal (exhibited as an
enhanced mammospehere formation), cell surface markers for
breast TICs (CD44
high/CD24
low) (Fig. 1A), and enhanced
tumorigenicity (Table 1). In agreement with the initial report of
Yu et al. [14], we noted that SK-3rd cells expressing GFP display
enhanced lung metastasis as compared to parental SK-BR3 cells
expressing GFP (Table 1).
It has been established that metastasis requires cancer cells
with enhanced invasive ability. To dissect the metastatic
process of SK-3rd TICs observed in vivo, a three-dimensional
(3-D) invasion assay was employed. Mammosphere-forming
SK-3rd TICs as well as parental SK-BR3 cells were assembled
in type I collagen gel and cultured under normoxic conditions
(21% O2) for 24 hours. Unexpectedly, the invasive ability of
SK-3rd TICs was only moderately increased as compared to
parental SK-BR3 cells, which lacked invasive ability (Fig. 1B &
C ) .T h i sr e s u l ti si n c o n s i s t e n tw i t ht h ein vivo studies (Table 1)
[14]. Given the evidence that SK-3rd TICs develop into
relatively rapid growing and metastatic tumors in vivo and rapid
growing solid tumors often contain regions lacking sufficient
oxygenation [15], we hypothesized that hypoxia may be
responsible for SK-3rd cell invasion and metastasis. To test
the effect of hypoxia on SK-3rd TIC invasion, we employed a
hypoxia-mimicking chemical agent, CoCl2, to recapitulate the
effects of hypoxia [16]. The effect of hypoxia on TIC invasion
was also assessed under 1% O2 atmosphere. Hypoxic condi-
tions were confirmed by Western blotting using antibody
against hypoxia-inducible factor-1a (HIF-1a), an intrinsic
marker of hypoxia [17] (Fig. 1D). SK-3rd and SK-BR3 cells
pretreated with CoCl2 or cultured under hypoxia (1% O2)w e r e
examined for their invasive abilities in the 3-D invasion assay.
Significantly increased cell invasion into surrounding type I
collagen was observed in SK-3rd TICs treated with CoCl2 as
compared to vehicle control. Similar result was observed when
the cells were cultured under hypoxic conditions (1%O2). In
contrast, parental SK-BR3 cells either treated with CoCl2 or
cultured under hypoxic conditions did not display enhanced
cell invasion (Fig. 1B & C). These data suggest that the invasive
a b i l i t yo fS K - 3 r dT I C si sr e g u l a t e db yh y p o x i a .
Relocation of MT1-MMP from Cytoplasmic Pools to the
Cell Surface Enhances TIC Invasion
A previously fine-tuned analysis of proteases with collagenase
activity suggested that only MT1-MMP confers the focal
collagenolytic activity necessary to support the tissue-invasive
cell phenotype [18]. To examine the role of MT1-MMP in
hypoxia-induced TIC invasion in 3-D type I collagen gels, both
loss- and gain-of-function assays were performed using our
previously generated MT1-MMP-GFP chimeric cDNA (MT1-
GFP) [12] and shRNAs against MT1-MMP [13]. Overexpress-
ing or silencing of MT1-MMP in SK-3rd TICs were character-
ized by Western blotting using anti-MT1-MMP antibody
(Fig. 2A). Silencing of MT1-MMP in SK-3rd TICs resulted in
a defect in cell invasion in the presence of CoCl2,w h e r e a s
overexpression of MT1-MMP in SK-3rd TICs significantly
enhanced cell invasion (Fig. 2B). These loss- and gain-of-function
assays led us to further analyze endogenous MT1-MMP
expression in SK-3rd using biochemical approaches. We first
examined basal levels of MT1-MMP expression in SK-3rd and
parental SK-BR3 cells by quantitative real time RT-PCR. MT1-
MMP was up-regulated more than ten-fold in SK-3rd cells
compared to parental SK-BR3 cells (Fig. 2C). Similar results
were found in TICs derived from human HT116 colon cancer
compared to its parental cells (Fig. 2C). This increase of MT1-
MMP mRNA correlated with protein expression levels as
examined in total cell lysates by Western blotting (Fig. 2D,
Middle panel, non CoCl2-treated SK-BR3 and SK-3rd). In
agreement with previous report [19,20], three forms of MT1-
MMP were detected in the total cell lysates. Since hypoxia was
found to increase TIC invasion (Fig. 1B), we asked if increased
invasive ability of SK-3rd under hypoxia was due to upregulated
MT1-MMP expression. Surprisingly, hypoxia did not change the
mRNA level of MT1-MMP in SK-3rd TICs in the presence
CoCl2 (Fig. 2E), suggesting that hypoxia plays a minimal role in
regulation of MT1-MMP gene expression.
It has been demonstrated that plasma membrane distribution
of MT1-MMP is required for its functionality [21]. To determine
if hypoxia-enhanced cell invasion is due to MT1-MMP cell
surface redistribution, a cell surface biotinylation assay followed
by Western blotting was performed. As demonstrated in
Figure 2D, the 54 kDa active form, as well as the degradation
product of MT1-MMP was increased on the cell surface of SK-
3rd TICs after 24 hours of CoCl2 treatment. Increased cell
surface MT1-MMP correlated with proMMP-2 activation
(Fig. 2D, Lower panel), indicative of functional MT1-MMP.
This observation was not seen in MT1-MMP-silenced SK-3rd
TICs (data not shown).
To examine the dynamic distribution of cell surface MT1-MMP
in response to CoCl2 treatment, SK-3rd TICs were treated with
CoCl2 followed by flow cytometry analysis. One to three days post
CoCl2-treatment, 1610
4 cells were used to gate the proportion of
positive stained cells at each time point and the percentage of
positive cells was determined. Dead cells were excluded by gating
out propidium iodide (PI)-positive cells. The population of SK-3rd
cells expressing cell surface MT1-MMP gradually increased under
CoCl2-treatment (Fig. 2F). To confirm this observation, a cell
surface biotinylation assay was performed. In agreement with the
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strated that active MT1-MMP (54 kDa) at the cell surface was
markedly and progressively increased over a three day period
(Fig. 2G, Upper panel). This increase was correlated with
functional MT1-MMP, as examined by gelatin zymography
(Fig. 2G, Lower panel). These observations suggest that MT1-
MMP is capable of converting less invasive, stationary TICs into
invasive cancer cells by promoting MT1-MMP relocation to
plasma membrane.
Figure 1. Hypoxia Enhances TIC Invasion. A) Characterization of SK-3rd TICs: SK-3rd and SK-BR3 cells were cultured on ultra-low attachment
culture dishes for 3 days and mammosphere formation was examined by microscopy (Upper panel). Bar, 100 mm. These cells were collected and
incubated with APC-conjugated anti-CD44 antibodies and PE-conjugated anti-CD24 antibodies followed by flow cytometry analysis (Lower panel). B–
C) Determination of invasive ability of SK-3rd TICs: SK-BR3 and SK-3rd cells were pretreated with or without CoCl2 (250 mM) or cultured under hypoxia
(1% O2) for 24 hours followed by examination of invasive ability of the cells using the 3-D invasion assay (B). After 24 hours, the cells were fixed and
invaded cells in six different fields in the invasion zone were microscopically counted (C). D) Evaluation of hypoxic conditions by examining HIF-1a in
SK-3rd cells: Total cell lysate from SK-3rd TICs pretreated with or without CoCl2 (250 mM) or under 1% O2 for 24 hours were examined by Western
blotting using anti-HIF-1a antibody. NT refers to cells without pre-hypoxia culture.
doi:10.1371/journal.pone.0038403.g001
MT1-MMP Converts Stationary TICs to Invasive Ones
PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e38403MT1-MMP Induces Dynamic Change of Cell Surface CD44
and Mammosphere-forming Ability under Hypoxic
Conditions
CD44 has been implicated as one of the TIC markers in
hematopoietic and epithelial malignancies [22,23]. Studies have
shownthatCD44isimplicatedinseveralcancerprocessesincluding
cell growth, adhesion, invasion, and metastasis [24]. To address the
effect of enhanced cell surface MT1-MMP on CD44 appearance in
TICs under hypoxic conditions, SK-3rd cells treated with CoCl2
were analyzed by flow cytometry using CD44 (APC-labeled) and
MT1-MMP (FITC-labeled) antibodies. Gradually increased cell
surface MT1-MMP was found to correlate with decreased cell
surfaceCD44(Fig.3A).DecreasedcellsurfaceCD44wasnotdueto
an effect of hypoxia on CD44 synthesis, as evidenced by real time
RT-PCR using CD44 specific primers (data not shown), suggesting
that increased MT1-MMP under hypoxia results in shedding of cell
surface CD44.To fortify this observation, conditioned mediumand
cell surface proteins were examined using biochemical approaches.
Treatment of SK-3rd TICs with CoCl2 resulted in diminished cell
surface CD44 (95 kDa), as examined by a cell surface biotinylation
assay. This decrease was accompanied by increased soluble CD44
(54 kDa) in the conditioned medium, as examined by Western
blottingusinganti-CD44antibodies(Fig.3B).Tocorrelateshedding
of CD44 with the loss of function, a hyaluronic acid adhesion assay
was performed to determine functionality of CD44 [25]. SK-3rd
TICs pretreated with CoCl2 for 24 hours were examined for
adhesive ability to hyaluronic acid-coated plates. Treatment of SK-
3rd cells with CoCl2 resulted in diminished cell adherence to
hyaluronic acid-coated plates, consistent with shedding of cell
surface CD44 (Fig. 3C).
Mammosphere formation is another intrinsic property of TICs.
To determine the effect of shedding of CD44 by MT1-MMP on
maintaining mammospheres of TICs, SK-3rd TICs were cultured
in ultra-low adherence plates in the hypoxic (1% O2) or normoxic
(21% O2) conditions for indicated times. Mammoshperes cultured
under hypoxic conditions gradually dissociated into single, isolated
cells (Fig. 3D, Upper panel). In contrast, mammospheres in
normoxic condition continued to expand. A similar result was
obtained in mammospheres derived from SK-3rd cells treated
with CoCl2 (Fig. 3D, Lower panel).
Toconfirmthisobservation,bothgain-andloss-of-functionassays
wereperformed.SK-3rdTICswerestablyinfectedwitharetrovirus
containing MT1-GFP chimeric cDNAs as well as GFP control
cDNAs. Overexpression of MT1-GFP inSK-3rd TICsresulted in a
decrease of CD44 as compared to GFP control examined by flow
cytometry (Fig. 3E, Lower panel). Furthermore, overexpressing
MT1-GFPinSK-3rdTICsresultedinlossofmammosphere-forming
ability(Fig.3E,Upperpanel).Intheloss-of-functionassay,silencing
ofendogenousMT1-MMP(shRNA-MT1)inSK-3rdcellsincreased
cell surface CD44 as compared to luciferase shRNA control. In
agreementwithincreasedCD44,silencingofMT1-MMPenhanced
mammosphere-forming ability (Fig. 3E, Lower panel). However,
both gain- and loss-of-function approaches had no notable effect on
tumorigenicity after orthotopically injecting 4610
3 tumor cells into
mice(Table1).ExpressionofCD24wasnotaffectedinbothgain-and
loss-of-function assays.
During metastasis, the oxygen environment surrounding cancer
cells undergoes dynamic changes. To determine if fluctuation of
oxygen tension affects MT1-MMP cell surface expression and the
subsequent change in cell surface CD44, SK-3rd TICs cultured
under hypoxia (1% O2) for 4 days were switched to normoxic
conditions for 1 to 4 days followed by flow cytometry analysis
using anti-MT1-MMP and anti-CD44 antibodies. Return to
normoxia was accompanied by a gradual decrease in display of
cell surface MT1-MMP and increase in cell surface CD44 (Fig. 3F).
These data suggest dynamic changes of properties of cancer stem-
like cells during cancer progression.
MT1-MMP Initiates Tumor Invasion and Metastasis in vivo
A previous study demonstrated that SK-3rd TICs display distant
metastasis in immunodeficient mice [14]. To determine the role of
MT1-MMP in SK-3rd TIC invasion and metastasis, both loss-of-
function (silencing endogenous MT1-MMP [shRNA-MT1] in SK-
3rdTICs)andgain-of-function(overexpressingofMT1-GFPinSK-
3rd TICs) were employed. These TICs (4610
3) were then injected
into mammary fat pads of NCR nude mice. Parental SK-BR3 cells
(4610
4) expressing GFP or MT1-GFP were used as controls. The
experiment was terminated after 4 weeks when the primary tumor
size reached 1.2 cm in diameter in mice bearing MT1-MMP-GFP
transfected cells. Except for SK-BR3 cells, all mice displayed visible
mammary tumors within 2 weeks after tumor cell injections,
indicatingthatMT1-MMPhadminimaleffectonultimateincidence
of tumor formation. However, SK-3rd cells overexpressing MT1-
GFPdisplayedmorerapidtumorgrowththancontrolcells,whereas
MT1-MMP silenced tumors had a slower growth rate than control
SK-3rd cells expressing luciferase shRNA (p,0.05) (Fig. 4A, B).
These observations indicate that MT1-MMP expression in TICs
enhances tumorgrowth in vivo.
Metastases from primary tumors were quantified by assessing
GFP fluorescence in lung tissue. Mice injected with MT1-GFP
overexpressing SK-3rd cells displayed larger volume pulmonary
metastasis than GFP overexpressing SK-3rd cells (Fig. 4C). In
contrast, diminished lung metastasis was found in mice injected
with MT1-MMP-silenced SK-3rd cells, suggesting the role of
MT1-MMP in TIC metastasis.
Breast TICs Possess Properties of EMT
Previous studies have demonstrated that the transcription factors
Twist-1 and Snail play essential roles in tumor metastasis [26,27].
Transfection of Twist-1 or Snail cDNAs into human mammary
epithelial cells (HMLE) resulted in conversion of epithelial cells to a
stem-like phenotype accompanied by EMT [28]. To address the
correlation between ‘‘stemness’’ and EMT in our TIC model, we
examinedEMTmarkersinculturedcancercellsemployingrealtime
RT-PCR and Western blot analysis. As compared to SK-BR3 cells,
SK-3rd cells displayed downregulated expression of epithelial
markers, E-cadherin, cytokeratins-8 and -18, and upregulated
expression of the mesenchymal marker, vimentin (Fig. 5A, B). In
Table 1. In Vivo Tumorigenicity and Spontaneous Metastasis
Assays.
Number of cells
4610
3 4610
4
Cell lines DNA Tumor Lung
Metastasis
Tumor Lung
Metastasis
SK-BR3 GFP n.d. n.d. 0/5 0/5
MT1- GFP n.d. n.d. 0/5 0/5
SK-3rd GFP 5/5 3/5 n.d. n.d.
MT1- GFP 5/5 4/5 n.d. n.d.
shRNA-Luc 5/5 3/5 n.d. n.d.
shRNAMT1 5/5 1/5 n.d. n.d.
‘‘n.d.’’=not done.
doi:10.1371/journal.pone.0038403.t001
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increasedinSK-3rdcellsascomparedtoSK-BR3(Fig.5C,D,&E).
We have previously demonstrated that MT1-MMP plays an
important role in epithelial cancer cell EMT [13]. To probe if
Twist-1 is an upstream regulator of MT1-MMP and subsequently
controls EMT, we silenced Twist-1 by shRNA in SK-3rd cells. A
significant decrease of MT1-MMP expression was detected by
Western blotting analysis (Fig. 5F), confirming the role of Twist-1 in
regulation of MT1-MMP.
Regulatory Mechanism of MT1-MMP in SK-3rd TICs
Although induction of MT1-MMP expression by growth factors
and cytokines has been reported [29], a detailed regulatory
mechanism of MT1-MMP expression remains elusive. Recent
reports have suggested that a cascade of miR10b-HoxD10 may
regulateMT1-MMPexpression,althoughitisunclearhowHoxD10
controls MT1-MMP expression [30,31]. To examine expression
level of miR10b in SK-3rd TICs, real time RT-PCR using specific
primers for miR10b was employed. miR10b was found only in SK-
3rd cells, as compared to parental SK-BR3 cells (Fig. 6A). This
observation is in agreement with a previous report [30,31] that
expression of Twist-1 resulted inelevated miR10b (Fig. 6B).
HoxD10hasbeenreportedtobeasuppressorofcellinvasionand
migration [32] and a direct target of miR10b [30]. Following
apparent binding to the promoter region of MT1-MMP, HoxD10
has been proposed to suppress MT1-MMP expression [31]. To
provide experimental evidence for this hypothesis, we silenced
miR10busingavectorencodinganti-senseofmiR10b,designatedas
miR10b sponge [30] in SK-3rd cells. Decreased miR10b in SK-3rd
TICs by miR10b sponge was confirmed by real time RT-PCR
(Fig. 6C). Silencing of miR10b resulted in increased HoxD10
expression in SK-3rd TICs examined by Western blotting analysis
(Fig.6Dupperpanel).ThisincreaseofHoxD10ledtodownregulated
MT1-MMP protein expression in the cells (Fig. 6D). To further
address the effect of miR10b-HoxD10 cascade on MT1-MMP
expression, miR10b was overexpressed in parental SK-BR3 cells.
Overexpressing of miR10b in SK-BR3 cells resulted in diminished
HoxD10 and increased MT1-MMPprotein expression (Fig. 6D).
Taken together, our data demonstrate a cascade of Twist1-
miR10b-HoxD10 in control of MT1-MMP expression. Further-
more, these data provide evidence for a mechanism of regulating
MT1-MMP expression in less invasive SK-3rd TICs under
normoxic conditions.
Discussion
In this study, we demonstrated that MT1-MMP is generally
expressed and stored in a non-functional cytoplasmic pool in
TICs. This upregulation of MT1-MMP is transcriptionally
controlled by a cascade involving Twist1-miR10b-HoxD10.
Under hypoxic conditions, which often occur in fast growing
tumors, MT1-MMP rapidly trafficks to the plasma membrane to
execute cell escape actions away from the hypoxic environment.
This process results in enhanced cell migration, invasion, and
metastasis. Our data demonstrate for the first time that less
invasive and stationary cancer stem-like cells can become more
motile and invasive under hypoxic conditions.
Due to technical limitations of maintaining TIC status in
culture, TICs have been difficult to study; this difficulty has
hampered anti-TIC drug discovery. Recent TIC research efforts
have advanced our capability for generating stable TIC lines
[14,28]. The SK-3rd TIC line used in this study meets current
definitions for TICs (cancer stem-like cells). This includes: 1)
mammosphere formation, which is a measure of self-renewal for
stem-like cells; 2) cell surface markers of breast TICs (CD44
high/C-
D24
low); and 3) in vivo tumorigenic capability requiring relatively
low number of cells. Although SK-3rd TICs display invasive
ability in type I collagen gel, this property of SK-3rd TICs is
minimal as compared to invasive breast cancer cell lines, such as
MDA-MB-231 (data not shown). In addition, the invasive ability
of SK-3rd TICs is markedly enhanced under hypoxic conditions.
Given these observations, SK-3rd TICs are considered less
invasive, stationary TICs.
Emerging evidence has indicated that the hypoxia that
accompanies solid tumors induces invasiveness of cancer cells
with stem-like properties [9,33]. Furthermore, hypoxia exerts a
pathophysiological selection pressure that leads to enhanced tumor
invasion and metastasis [10,34]. In the current study, two
experimental models were used to mimic a hypoxic environment:
a hypoxia chamber with 1% O2 and a well-known hypoxia
mimetic agent, CoCl2. Both models work via stabilizing HIF-1a.
This has been confirmed by Western blotting using anti-HIF-1a
antibody in our working system (Fig.1D). Although similar results
were obtained using these two models, we found that the effect of
CoCl2 on MT1-MMP-induction lasts longer compared to that
induced by the hypoxia chamber, when cells were switched from
hypoxic to normoxic conditions (data not shown).
Figure 2. Hypoxia induces intracellular MT1-MMP trafficking to the cell surface, resulting in enhanced invasiveness of SK-3rd cells.
A) Determination of MT1-MMP expression in SK-3rd cells: Total cell lysates from SK-3rd cells either overexpressing of MT1-GFP or silencing of
endogenous MT1-MMP were analyzed by Western blotting using anti-MT1-MMP antibodies. b-Actin was used as a loading control. B) Examination of
the role of MT1-MMP in SK-3rd TIC invasion: SK-3rd TICs with overexpression or downregulation of MT1-MMP as indicated were pretreated with or
without CoCl2 (250 mM) for 24 hours followed by evaluation of cell invasive ability in the 3-D invasion assay (Left panel). The invaded cells were
microscopically counted (Right panel). Hypoxia promotes SK-3rd TIC invasion and this process requires expression of MT1-MMP in the cells. C)
Expression of MT1-MMP in TICs: Total RNAs from breast cancer cells (SK-BR3 parental cells and SK-3rd TICs) and colon cancer cells (HCT116 parental
cells and HCT116 TICs) were examined for the expression of MT1-MMP using a real time RT-PCR approach. Housekeeping genes (GAPDH and HPRT)
were used to normalize MT1-MMP mRNA in all samples. D) Determination of functional MT1-MMP in SK-3rd TICs: Top panel: Cell surface MT1-MMP in
SK-BR3 and SK-3rd cells treated with or without CoCl2 for 24 hours were biotinylated and precipitated with streptavidin-beads followed by Western
blotting using anti-MT1-MMP antibodies. Densitometry analysis was performed and ratios between MT1-MMP latent and active forms over b-actin
were given. Middle panel: An aliquot of total cell lysates of cell surface biotinylated SK-BR3 and SK-3rd cells were examined by Western blotting using
anti-MT1-MMP antibodies. b-actin was used as a loading control. Densitometry analysis was performed and ratios between MT1-MMP latent and
active forms over b-actin were given. Bottom panel: The conditioned medium in the presence of recombinant proMMP-2 was examined by gelatin
zymogram to determine functional MT1-MMP. E) Effect of CoCl2 on MT1-MMP expression: SK-BR3 and SK-3rd cells treated with or without CoCl2
(250 mM) for 24 hours were examined by real time RT-PCR using MT1-MMP specific primers and housekeeping genes for normalization. F–G)
Correlation of cell surface expression of MT1-MMP with proMMP-2 activation: SK-3rd TICs pretreated with CoCl2 (Pre CoCl2; 250 mM) for 24 hours were
switched to complete medium in the absence of CoCl2 (Post CoCl2) for indicated dates followed by flow cytometry analysis using anti-MT1-MMP
antibody (F). The cells were also examined by cell surface biotinylation experiment using antibodies for MT1-MMP (G, Upper panel) and b-actin (G,
loading control, Middle panel), and gelatin zymogram (G, Lower panel) and input of MT1-MMP (Bottom panel). Densitometry analysis was performed
and ratios between MT1-MMP active form over b-actin was given.
doi:10.1371/journal.pone.0038403.g002
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e38403Figure 3. Effect of hypoxia-induced cell surface MT1-MMP on cell surface CD44 and mammosphere formation. A–B) Cell surface CD44
inversely correlates with hypoxia-induced cell surface MT1-MMP: SK-3rd TICs were cultured in the presence of CoCl2 (Pre CoCl2; 250 mM) for 24 hours
and then switched to CoCl2-free medium (Post CoCl2) for indicated times. Flow cytometry analysis employing APC-anti-CD44 antibodies and anti-
MT1-MMP antibodies in conjunction with FITC-labeled secondary antibodies (A). Cell surface proteins were biotinylated and examined for CD44
appearance (B, Upper panel). Shed CD44 in the conditioned medium was examined by Western blotting using anti-CD44 antibodies (B, Middle panel).
b-actin was used as a loading control (B, Lower panel). Ponceau staining of the membrane with samples from the conditioned medium was
employed as a loading control. C) Effect on cell adhesion by hypoxia using a hyaluronic acid adhesion assay: SK-3rd TICs treated with or without CoCl2
(250 mM) for 24 hours were examined for their ability to adhere to hyaluronic acid-coated 96-well tissue culture plates. The adherent cells were
enumerated based on calcein staining. D) Dissociation of mammospheres by low oxygen (Upper panel) or CoCl2 treatment: Mammospheres from SK-
3rd TICs were cultured under either 21% O2 or 1% O2 or treated with CoCl2 (250 mM) for indicated times. The cells were microscopically examined
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PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e38403Despite continuous progress in identifying potential therapeutic
targets for prevention of metastasis, the contribution and timing of
key regulators remains unclear [35]. Regardless of which molecules
are primarily responsible for initiating cancer dissemination,
mounting evidence has demonstrated that cancer cells and TICs
require proteases for their invasive behavior. We focused on a key
cell surface-anchored protease, MT1-MMP, to characterize the
mechanism of hypoxia-induced TIC invasion in type I collagen gel.
This is based on a recent report demonstrating that MT1-MMP is
the only protease responsible for the focal collagenolytic activity
necessarytoenhancetumorcellinvasion[36].Ourdatasupportthat
MT1-MMP plays a key role in enhancing TIC invasion in type I
collagen gel. Since MT1-MMP is highly expressed in most human
cancers [37], utilization of cell surface MT1-MMP as a cancer-
homing molecule for delivering potent cytotoxic drugs, particularly
to invasive TICs, provides a viable approach to enhance cancer cell
target selectivity and specificity.
Compared to parental breast cancer SK-BR3 cells, expression
level of MT1-MMP in SK-3rd TICs is elevated. Although MT1-
MMP has been identified for more than a decade [38], the
regulatory mechanism of MT1-MMP remains to be characterized.
Growth factors and cytokines have been reported to induce MT1-
MMP expression [37]. Our studies demonstrate that Twist-1 is
upregulated in SK-3rd TICs, which exhibit an EMT phenotype
(Fig. 5A, B). Twist-1 has previously been reported to play an
essential role in cancer cell EMT and subsequently tumor invasion
daily. Bar, 100 mm. E) Effect of MT1-MMP on mammosphere forming ability and cell surface CD44 expression: SK-3rd TICs were infected with retrovirus
containing cDNAs for GFP or MT1- GFP and shRNAs against luciferase (shRNA-Luc) or MT1-MMP (shRNA-MT1). The cells were cultured in ultra-low
attachment culture dishes for their mammosphere forming abilities (Upper panel) and cell surface expression of CD44 and CD24 were examined by
flow cytometry using corresponding antibodies (Lower panel). F) Reversal of hypoxia-induced MT1-MMP under normoxic conditions: SK-3rd TICs
were cultured under 1% O2 for 24 hours and then switched to normoxic conditions for indicated time. Flow cytometry analysis was performed using
anti-CD44 and anti-MT1-MMP antibodies. NT refers to non-hypoxia-cultured cells.
doi:10.1371/journal.pone.0038403.g003
Figure 4. MT1-MMP is required for metastasis of SK-3rd TICs. SK-3rd TICs expressing exogenous genes for either upregulation or
downregulation of MT1-MMP as indicated were injected into immunodeficient mice and tumor growth was monitored (A). After four weeks, the
experiments were terminated and entire tumor was harvested and weighed (B). The lungs were examined under phase contrast (C, Lift upper panel)
and fluorescent (Right lower panel) microscopy. Metastasized tumors were identified based on GFP auto-fluorescence and measured using Nikon NIS
Elements. Quantification of total lung metastasis burden in mice bearing tumor cells as indicated was determined based on percentage of
metastasized tumors (area) over lungs (area) under the same field (C, Right panel). Bar, 100 mm.
doi:10.1371/journal.pone.0038403.g004
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PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e38403and metastasis [27]. We previously reported that MT1-MMP
plays an important role in prostate cancer cell EMT [13]. A
possible link between Twist-1 and MT1-MMP in EMT is
proposed. Indeed, silencing of Twist-1 gene expression in SK-
3rd TICs significantly reduced MT1-MMP protein expression
(Fig. 5F). This is in part due to the upregulated Twist-1 in SK-3rd
TICs leading to miR10b production, which then suppresses a
MT1-MMP transcriptional suppressor, HoxD10, resulting in
upregulated MT1-MMP in TICs cultured under normoxic
conditions (Fig. 6D). This hypothesis is supported by the
demonstration that overexpression of miR10b in parental SK-
BR3 cells resulted in increased MT1-MMP expression. Converse-
ly, silencing of miR10b expression in SK-3rd TICs significantly
reduced MT1-MMP expression. Our results provide experimental
evidence to support hypotheses proposed in recent reports
[30,31,39].
Hypoxia has been reported to induce MT1-MMP expression in
retinal glial cells and hepatocellular carcinoma cells using a
standard RT-PCR approach [40,41]. However, using real time
quantitative RT-PCR, we demonstrate that hypoxia does not
induce MT1-MMP mRNA and protein expression in breast
cancer TICs. Instead, hypoxia results in trafficking of preexisting
MT1-MMP in SK-3rd TICs from cytoplasmic storage pools to cell
surface, which is in agreement with a previous report showing that
hypoxia induced MT1-MMP cell surface translocation in MDA-
MB-231 cells [42]. Our data showing that treatment of parental
SK-BR3 cells with CoCl2 did not enhance cell invasion is
supportive of our observation that MT1-MMP expression is not
regulated by hypoxia. Storage of MT1-MMP in cytoplasmic
storage pools has been previously reported in other cancer cell
lines [29]. Upon stimulation, MT1-MMP relocates from the
storage pool to the cell surface possibly via Rab8 [43] and VAMP7
[44] pathways. Based on other reports, it is suggested that hypoxia
promotes RhoA-dependent trafficking of MT1-MMP to the
plasma membrane [42]. Furthermore, we have recently shown a
role for the chaperone protein, Hsp90a, in trafficking of MT1-
MMP to the plasma membrane (manuscript in preparation).
Currently, isolation of cancer stem-like cells has been mainly
based on cell surface marker and tumor-sphere formation.
Indeed, in addition to tumorigenic capability, expression of cell
surface CD44 and the ability to form tumor-spheres are two
intrinsic markers of cancer stem-like cells [45]. However, we
observed that culture of SK-3rd TICs or colon TICs under
hypoxic conditions resulted in a gradual increase in cell surface
MT1-MMP and decrease in cell surface CD44 expression, as
examined by flow cytometry, cell surface biotinylation, and
cellular functional assays for CD44 and MT1-MMP (Fig. 2F &
G). Furthermore, increased MT1-MMP with diminished CD44
at the cell surface of SK-3rd TICs results in dissociation of
mammospheres (Fig. 3E). These observations are consistent with
the concept that the plasticity of TICs undergoes dynamic
changes at different stages of metastasis. In a separate study, we
observed the reappearance of E-cadherin, a cell-cell junction
adhesion molecule, in MT1-MMP transfected LNCaP prostate
tumors at metastatic sites in the lungs (high oxygen content)
compared with the primary tumor in samples from an orthotopic
prostate cancer model (manuscript in preparation). Since the
current procedure for isolation of TICs from human cancer
specimens is commonly based on cell surface markers and the
ability to form mammospheres, our data suggest that invading/
metastasizing TICs may not be identified using these criteria due
to a dynamic change in CD44 and mammosphere-forming
Figure 5. SK-3rd TICs possess properties of EMT. A–B) Differential expression of EMT markers in SK-3rd TICs: SK-BR3 and mammosphere
forming SK-3rd cells were examined by real time RT-PCR (A) and Western blotting (B) for expression of EMT markers. E-cad: E-cadherin; Vim: Vimentin;
Cytok: cytokeratin. C–E) Upregulation of Twist-1 in SK-3rd TICs: The total RNA of SK-BR3 and SK-3rd cells was examined for expression of Twist-1 and
Snail using real time RT-PCR (C). Housekeeping genes were used to normalize Twist-1 and Snail mRNAs in all samples. At the end of real time RT-PCR,
the samples were examined in a 1.2% agarose gel (D). The cell lysates from nuclear fractions were examined by Western blotting using anti-Twist-1
antibodies (E, Upper panel). Histone 3 was used as a loading control for nuclear preparation. F) Effect of Twist-1 on MT1-MMP expression: SK-3rd TICs
silenced for Twist-1 or GFP control were examined by Western blotting using antibodies as indicated for expression of MT1-MMP and Twist-1. b-actin
was used as a loading control.
doi:10.1371/journal.pone.0038403.g005
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and decrease of cell surface CD44 by hypoxia-upregulated MT1-
MMP in SK-3rd cells excludes these cells from being considered
stem-like cells is a semantic one, since plasticity is a recognized
aspect of stem-like cells and we demonstrated that four days after
return to normoxia, partial restoration of the stem-like cell
phenotype of SK-3rd TICs occurs.
Mesenchymal cells need to be reconverted to an epithelial
phenotype (MET) in order for TICs to proliferate at distant
metastatic sites [46]. Hypoxia-induced MT1-MMP appearance on
the cell surface persists for four days after returning to normoxia
(Fig. 3F). This time period is consistent with the slow extravasation
of cells from the vasculature during breast cancer micrometastasis
[47]. In addition, when hypoxia-cultured TICs returned to
normoxic conditions for a longer time period, cell surface MT1-
MMP gradually disappeared. Conversely, cell surface CD44
reappeared (Fig. 3F). These observations support phenotypic
transition in response to changes in the microenvironment,
referred to as EMT and MET conversion. Due to technical
limitations in capturing the critical role of MT1-MMP cell surface
trafficking during EMT and MET dynamic changes in vivo,
monitoring MT1-MMP turnover using the hypoxia-normoxia
in vitro switching model will help us to better understand this
important aspect of metastasis.
Of relevance to our studies, Biddle et al. [48] have isolated a TIC
subpopulation from human oropharyngeal cancer cells that have
undergone EMT and are migratory. The EMT (sphere-forming,
migratory, and metastatic in vivo) and non-EMT (rapid proliferation
as adherent and less metastatic cells) TIC populations coexist by
switchingbetweentheirphenotypes.TheyproposedthatTICshave
the ability to take on an EMT phenotype for migration to a
secondary site, before reverting back to the proliferative non-EMT
phenotype to enable formation of a metastatic tumor at that
secondary site. This experimental EMT-MET conversion is
consistent with the theory proposed by Brabletz et al [8]. Our
studies describing the role of hypoxic-induction of MT1-MMP
trafficking to the cell surface as being of central importance in the
Figure 6. miR10b regulates MT1-MMP through HoxD10. A–C) Expression of miR10b in SK-3rd TICs or Twist-1 silenced-SK-3rd TICs: Total RNA
was examined for expression of miR10b in cells as indicated by real time RT-PCR. Housekeeping gene (RNU6B) were used to normalize miR10b in all
samples. D) Effect of miR10b on HoxD10 and MT1-MMP expression: Total cell lysates from cells as indicated were examined by Western blotting using
anti-HoxD10 and MT1-MMP antibodies, respectively. b-actin was used as a loading control.
doi:10.1371/journal.pone.0038403.g006
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PLoS ONE | www.plosone.org 10 June 2012 | Volume 7 | Issue 6 | e38403conversion of stationary to invasive TICs provides a mechanistic
explanation for EMT-MET in cancer metastasis.
In conclusion, we have demonstrated for the first time that
hypoxia induces the conversion of less invasive and stationary
TICs to become invasive and metastatic by promoting MT1-
MMP cell surface trafficking. Effect of oxygen tension on plasticity
of TICs regulates metastatic process via MT1-MMP cell surface
appearance and disappearance. Hence, targeting MT1-MMP
represents a viable approach for preventing cancer dissemination.
Materials and Methods
Reagents
Type 1 collagen (acetic acid-extracted native type 1 collagen
from rat-tail tendon) was purchased from BD Bioscience Discovery
Labware (Bedford, MA). EZ-link Sulfo-NHS-S-S-Biotin was
purchased from Pierce. RNAi-Ready pSIREN-RetroQ and GFP
vectors were purchased from Clontech (Mountain View, CA).
Plasmid DNAs including MDH1-PGK-GFP 2.0 [49], MDH1-
PGK-GFP miR10b [30] and pBabe-puro-miR10b sponge [50]
were purchased from Addgene (Cambridge, MA). Primary
antibodies were purchased from Abcam (Cambridge, MA; anti-
MT1-MMP hinge polyclonal antibody), Cell Signaling Technol-
ogy (Beverly, MA, anti-b-actin and anti-a,b-tubulin antibodies),
Santa Cruz (Santa Cruz, CA, anti-vimentin, anti-cytokeratin8/18,
anti-HCAM (CD44) and anti-HoxD10 antibodies), BD Bioscienc-
es (San Jose, CA, anti-HIF-1aantibody), and Zymed Laboratories
Inc (Carlsbad, CA, anti-E-cadherin antibody against extracellular
portion). Secondary antibodies (anti-Mouse and anti-Rabbit IgG)
were purchased from Rockland Immunochemicals (Gilbertsville,
PA). Recombinant pro-MMP-2 was produced in COS-1 cells
transfected with MMP-2 cDNA [51].
Cell Culture
The SK-3rd cells were maintained as previously described [14].
TheSK-3rdcellswereculturedinultra-lowattachmentculturedishes
(Corning) in suspension with serum-free DMEM-F12 (Cellgro)
mediumsupplementedwithB27(1:50,Invitrogen),20 ng/mLEGF
(BDBiosciences),0.4%bovineserumalbumin(Sigma),and4 mg/mL
insulin (Sigma) [52]. SK-BR3 cells were cultured in McCoy’s 5A
medium (Gibco) supplemented with fetal bovine serum (Invitrogen)
toafinalconcentrationof10%.BothSK-3rdandSK-BR3cellswere
cultured under a5%CO2 atmosphere.
Mammosphere Culture
Mammosphere culture was performed as previously described
[52]with a slight modification. Cells (1000 cells/ml) were cultured
in ultra-low attachment culture dishes in suspension for 12 days.
For sphere passage in vitro, spheres were collected by gentle
centrifugation, dissociated to single cells, and then cultured to
generate mammospheres for the next generation.
Flow Cytometry Analysis
APC-conjugated anti-CD44 (Clone G44-26) antibody, PE-
conjugated anti-CD24 antibody (clone ML5) and propidium
iodide (PI) (10 mg/mL) were purchased from BD Biosciences and
used for flow cytometry analysis in accordance with the
manufacturer’s protocols. 1610
6 cells/ml suspended in PBS
containing 2% BSA were incubated with CD44/CD24 conjugated
antibodies or anti-MT1-MMP hinge polyclonal antibody for
60 min at 4uC followed by incubation with anti-rabbit FITC-
labeled (1:1000) secondary antibody for 60 min at 4uC (for MT1-
MMP staining). After extensive washing, the cells were stained
with PI to determine viability of the cells. Cell surface CD44,
CD24, and MT1-MMP expression was measured using a FACS
Calibur flow cytometer (BD Biosciences). Only the PI negative cell
population was gated for further analysis.
RNA Isolation and Real Time Reverse Transcription-PCR
Total RNAs were isolated from cultured cells using a RNA
Purification kit (QIAGEN, Valencia, CA). Reverse transcription
was performed using a Bio-Rad iScript cDNA synthesis kit based
on product instructions. The resultant cDNAs were used for PCR
using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA) in
triplicates. PCR and data collection were performed on MyIQ2
real time PCR system (Bio-Rad). The relative quantitation value
for each target gene compared with the endogenous controls
(GAPDH and HPRT) for that target was analyzed by a DDCT
method (MyIQ2 software; Bio-Rad).
The primer sets used for real time RT-PCR were as follows:
MT1-MMP (NM_004995), sense (cactgcctacgagaggaagg) and anti-
sense (ttggggtactcgctatccac); cytokeratin-8 (M342250), sense
(ccgacgagatcaacttcctc) and anti-sense (ggctctgcagctcctcatac); cyto-
keratin-18 (X12881), sense (aaaggcctacaagcccagat) and anti-sense
(cactgtggtgctctcctcaa); vimentin (NM_003380), sense (ccctcacctgt-
gaagtggat) and anti-sense (tccagcagcttcctgtaggt); GAPDH
(NM_002046), sense (ctcatgaccacagtccatgc) and anti-sense (tttcta-
gacggcaggtcagg); HPRT1 (NM_000194), sense (accccacgaagtgttg-
gata) and anti-sense (aagcagatggccacagaact); Snail (NM_005985),
sense (gcgagctgcaggactctaat) and anti-sense (cccactgtcctcatctgaca)
andTwist1 (NM_000474), sense (gtccgcagtcttacgaggag) and anti-
sense (ccagcttgagggtctgaatc).
For microRNA (miRNA) analysis, total RNAs, including miR-
NAs, were isolated from the cell lines using TRIzol reagent
(Invitrogen Corporation) in accordance with the manufacturer’s
instructions. Ten nanograms of total RNAs from each cell line were
converted to cDNA using the High-Capacity cDNA synthesis kit
(Applied Biosystems). The miRNA sequence-specific reverse tran-
scription primers for miR-10b and an endogenous control RNU6B
were purchased from Ambion (Austin, TX, USA). Real-time
quantitative RT-PCR analysis was performed using the 7500 Real-
TimePCRSystem(AppliedBiosystems).Therelativequantification
value was calculated using the comparative CT (DDCT) method
(AppliedBiosystems)andnormalizedbytheexpressionoftheinternal
control RNU6B.Three independent experiments were performed.
Hyaluronic Acid Adhesion Assay
96-well tissue culture plates were coated with 3 mg/ml
hyaluronic acid in PBS or 2% BSA as a control overnight at
4uC. Nonspecific sites were blocked with 2% BSA for 10 minutes
at room temperature. The wells were washed with PBS and seeded
with cells (60,000 cells/well) previously incubated with 2.5 mM
calcein in phenol-free medium. Adhesion was allowed to proceed
at 37uC for 1 h. The wells were then washed two times with PBS,
and plate was read on a Molecular Devices Gemini EM (excitation
494, emission 517).
Animal Experiments
The tumorigenicity study was performed by orthotopic
injection of tumor cells with 50% Matrigel into the mammary fat
pad of NCR-Nu-M female mice (4–5 wks old) (Taconic). Tumor
incidence was monitored and tumor size was measured twice per
week.Afterfourweeks,themiceweresacrificedandprimarytumors
were resected. Major organs were also harvested and examined for
tumor metastasis based on GFP autofluorescence.
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Data are expressed as the mean 6 S.E. of triplicates. Each in
vitro experiment was repeated as least 3 times. Student’s t test and
analysis of variants were used to assess differences with p,0.05
considered to be significant.
Construction of Small Interference RNA Vectors and
Retroviral Infection, Gelatin Substrate Zymography,
Cell Surface Biotinylation, MTT proliferation assay, and
Western Blot analysis
Basic protocols for above techniques have been described
previously [12,13].
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